Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046904 · ClinicalTrials.gov registry record · Phase 3
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
A Phase 3 study of Unspecified Adult Solid Tumor, Protocol Specific and Cachexia, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 19
- Study locations
NCT00046904 is a Phase 3 study of Unspecified Adult Solid Tumor, Protocol Specific and Cachexia that has completed, run by Mayo Clinic. The trial reports 19 study locations across 15 states.
The verdict
NCT00046904, a Phase 3 study of Unspecified Adult Solid Tumor, Protocol Specific and Cachexia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 19
- Study locations
Study Summary
RATIONALE: Etanercept is a substance that is being studied as a treatment for cachexia (weight loss) and anorexia (lack of appetite) in patients who have cancer. It is not yet known whether etanercept is effective in improving cancer-related cachexia and anorexia. PURPOSE: Randomized phase III trial to determine the effectiveness of etanercept in treating cancer-related cachexia and anorexia in patients who have advanced cancer.
Conditions Studied
Interventions
- BIOLOGICAL etanercept
Study Locations (19)
Iowa
- CCOP - Cedar Rapids Oncology Project - Cedar Rapids
- CCOP - Iowa Oncology Research Association - Des Moines
- Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center - Sioux City
Illinois
- CCOP - Illinois Oncology Research Association - Peoria
- CCOP - Carle Cancer Center - Urbana
South Dakota
- Rapid City Regional Hospital - Rapid City
- CCOP - Sioux Community Cancer Consortium - Sioux Falls
Alabama
- MBCCOP - Gulf Coast - Mobile
Arizona
- Mayo Clinic Scottsdale - Scottsdale
Florida
- Mayo Clinic - Jacksonville - Jacksonville
Hawaii
- MBCCOP - Hawaii - Honolulu
Kansas
- CCOP - Wichita - Wichita
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00046904
The ClinicalTrials.gov registry entry for NCT00046904 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Unspecified Adult Solid Tumor, Protocol Specific appearing as the primary indexed condition, and to 1 intervention - of which etanercept is the first listed.
NCT00046904 reports 19 study locations spanning 15 distinct geographic areas - top geographies include Iowa, Illinois, South Dakota.
Frequently Asked Questions
What is clinical trial NCT00046904 about?
NCT00046904 is a clinical study titled "Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer". RATIONALE: Etanercept is a substance that is being studied as a treatment for cachexia (weight loss) and anorexia (lack of appetite) in patients who have cancer. It is not yet known whether etanercept is effective in improving cancer-related cachexia and anorexia. PURPOSE: Randomized phase III tria...
What is the current status of trial NCT00046904?
This trial is currently completed. It is a Phase 3 study. The study started on 2003-05.
What conditions does trial NCT00046904 study?
This clinical trial studies the following conditions: Unspecified Adult Solid Tumor, Protocol Specific, Cachexia, Anorexia.
What interventions are being tested in trial NCT00046904?
The interventions under investigation include: etanercept (BIOLOGICAL).
Who is sponsoring clinical trial NCT00046904?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00046904 being conducted?
This trial has 19 study locations across Alabama, Arizona, Florida, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unspecified Adult Solid Tumor, Protocol Specific
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
COMPLETED · Phase 3
-
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
COMPLETED · Phase 3
-
Levocarnitine in Treating Fatigue in Cancer Patients
COMPLETED · Phase 3
-
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
COMPLETED · Phase 3
-
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
COMPLETED · Phase 3
-
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.